Related references
Note: Only part of the references are listed.Role of TAPP1 and TAPP2 adaptor binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis
Stephan Wullschleger et al.
BIOCHEMICAL JOURNAL (2011)
Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner
Min Sup Song et al.
CELL (2011)
Amino Acid Signaling to mTOR Mediated by Inositol Polyphosphate Multikinase
Seyun Kim et al.
CELL METABOLISM (2011)
Targeting the PI3K signaling pathway in cancer
Kwok-Kin Wong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo
Michael J. Jurynec et al.
DISEASE MODELS & MECHANISMS (2010)
Tyrosine phosphorylation of SHIP promotes its proteasomal degradation
Jens Ruschmann et al.
EXPERIMENTAL HEMATOLOGY (2010)
SHIP2 and its involvement in various diseases
Akira Suwa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Protein phosphatase 2A PR130/Bα1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling
Karen Zwaenepoel et al.
FASEB JOURNAL (2010)
The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics
Fubito Nakatsu et al.
JOURNAL OF CELL BIOLOGY (2010)
Differential Phosphoproteomics of Fibroblast Growth Factor Signaling: Identification of Src Family Kinase-Mediated Phosphorylation Events
Debbie L. Cunningham et al.
JOURNAL OF PROTEOME RESEARCH (2010)
SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity
E. Charlier et al.
LEUKEMIA (2010)
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
Clare G. Fedele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease
Lisa M. Ooms et al.
BIOCHEMICAL JOURNAL (2009)
SHIP2 (SH2 Domain-containing Inositol Phosphatase 2) SH2 Domain Negatively Controls SHIP2 Monoubiquitination in Response to Epidermal Growth Factor
Julie De Schutter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mutations in Phosphoinositide Metabolizing Enzymes and Human Disease
Heather J. McCrea et al.
PHYSIOLOGY (2009)
Charting the molecular network of the drug target Bcr-Abl
Marc Brehme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS
Serhiy Havrylov et al.
PROTEOME SCIENCE (2009)
Ins(1,4,5)P3 3-kinase-A overexpression induces cytoskeletal reorganization via a kinase-independent mechanism
Sabine Windhorst et al.
BIOCHEMICAL JOURNAL (2008)
The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity
Jingwei Xie et al.
CELLULAR SIGNALLING (2008)
SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF
Jingwei Xie et al.
FEBS LETTERS (2008)
Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics
Philipp Mertins et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia
Jia Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The association between the SH2-Containing inositol polyphosphate 5-phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners
Sheela Onnockx et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2
Ian H. Batty et al.
BIOCHEMICAL JOURNAL (2007)
Phosphoinositide phosphatases in a network of signalling reactions
Daniel Blero et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway
Kai S. Erdmann et al.
DEVELOPMENTAL CELL (2007)
The inositol 5′-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production
Wai-Hang Leung et al.
JOURNAL OF IMMUNOLOGY (2007)
The PI3K effector Arap3 interacts with the PI(3,4,5)P3 phosphatase SHIP2 in a SAM domain-dependent manner
Judith H. Raaijmakers et al.
CELLULAR SIGNALLING (2007)
Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth
Sonia Severin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-kinase-dependent Rac1 activation
Guanglei Zhuang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks
Jesper V. Olsen et al.
CELL (2006)
Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence
P Schnupf et al.
CELLULAR MICROBIOLOGY (2006)
The inositol phosphatase SHIP-2 down-regulates FcγR-mediated phagocytosis in murine macrophages independently of SHIP-1
J Ai et al.
BLOOD (2006)
SHIP2 interaction with the cytoskeletal protein Vinexin
N Paternotte et al.
FEBS JOURNAL (2005)
The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading
A Koch et al.
ONCOGENE (2005)
The type Iα inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane
I Ivetac et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
SH2-containing 5′-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent downregulation of the epidermal growth factor receptor
NK Prasad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity
MW Sleeman et al.
NATURE MEDICINE (2005)
Cell migration: Rho GTPases lead the way
M Raftopoulou et al.
DEVELOPMENTAL BIOLOGY (2004)
SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels
S Giuriato et al.
BIOCHEMICAL JOURNAL (2003)
SHIP-2 inositol phosphatase is inducibly expressed in human monocytes and serves to regulate Fcγ receptor-mediated signaling
RA Pengal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2
I Vandenbroere et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin
JM Dyson et al.
JOURNAL OF CELL BIOLOGY (2001)
The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells
X Pesesse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
SH2-containing inositol 5′-phosphatase SHIP2 associates with the p130Cas adapter protein and regulates cellular adhesion and spreading
N Prasad et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The lipid phosphatase SHIP2 controls insulin sensitivity
S Clément et al.
NATURE (2001)
The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of FcγRIIB in B cells under negative signaling
E Muraille et al.
IMMUNOLOGY LETTERS (2000)
5 ' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells
V Taylor et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
